Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleProceedings of the 2013 Viral Clearance Symposium

Viral Inactivation: Low pH and Detergent

Laura Durno and Omar Tounekti
PDA Journal of Pharmaceutical Science and Technology January 2015, 69 (1) 163-172; DOI: https://doi.org/10.5731/pdajpst.2015.01040
Laura Durno
1Health Canada, Biologics and Genetic Therapies Directorate, Centre for the Evaluation of Radiopharmaceuticals and Biotherapeutics, Tunney's Pasture, 100 Eglantine Driveway, Ottawa, Canada, K1A 0K9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: laura.durno@hc-sc.gc.ca omar.tounekti@hc-sc.gc.ca
Omar Tounekti
1Health Canada, Biologics and Genetic Therapies Directorate, Centre for the Evaluation of Radiopharmaceuticals and Biotherapeutics, Tunney's Pasture, 100 Eglantine Driveway, Ottawa, Canada, K1A 0K9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: laura.durno@hc-sc.gc.ca omar.tounekti@hc-sc.gc.ca
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 69 no. 1 163-172
DOI 
https://doi.org/10.5731/pdajpst.2015.01040
PubMed 
25691724

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online February 17, 2015.

Copyright & Usage 
© PDA, Inc. 2015

Author Information

Cited By...

  • 12 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
    Majed Ghattas, Garima Dwivedi, Marc Lavertu, Mohamad-Gabriel Alameh
    Vaccines 2021 9 12
  • Cathepsin L Causes Proteolytic Cleavage of Chinese‐Hamster‐Ovary Cell Expressed Proteins During Processing and Storage: Identification, Characterization, and Mitigation
    Haibin Luo, Liu Tie, Mingyan Cao, Alan K. Hunter, Timothy M. Pabst, Jiali Du, Raymond Field, Yuling Li, William K. Wang
    Biotechnology Progress 2019 35 1
  • Characterization of operating parameters for XMuLV inactivation by low pH treatment
    Shivanthi Chinniah, Peter Hinckley, Lisa Connell-Crowley
    Biotechnology Progress 2016 32 1
  • Identification of compendial nonionic detergents for the replacement of Triton X‐100 in bioprocessing
    Alan K. Hunter, Kamiyar Rezvani, Matthew T. Aspelund, Guoling Xi, Dhanesh Gadre, Thomas Linke, Kang Cai, Sri Hari Raju Mulagapati, Tomasz Witkos
    Biotechnology Progress 2022 38 2
  • Biopharmaceutical Processing
    Krunal K. Mehta, Ganesh Vedantham
    2018
  • Process Scale Purification of Antibodies
    Brian Kelley
    2017
  • Decreasing hydrophobicity or shielding hydrophobic areas of CH2 attenuates low pH-induced IgG4 aggregation
    Qiang Wu, Chunlai Cao, Suzhen Wei, Hua He, Kangyue Chen, Lijuan Su, Qiulian Liu, Shuang Li, Yongjie Lai, Jing Li
    Frontiers in Bioengineering and Biotechnology 2023 11
  • Viral safety for biotherapeutics and biosimilar
    Horst Ruppach
    Drug Discovery Today: Technologies 2020 37
  • Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants
    Robert Pejchal, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez, Eric M. Krauland
    Antibodies 2023 12 3
  • Biopharmaceutical Processing
    Brian D. Kelley, Annika Kleinjans, Philip Lester
    2018
  • Vaccine formulation design: challenges and opportunities
    Saman Zafar, Ambreen Akhtar, Elshaimaa Sayed, Ekhoerose Onaiwu, Muhammad Sohail Arshad, Zeeshan Ahmad
    RSC Pharmaceutics 2025
  • Viral clearance capability of monoclonal antibody purification
    Kang Cai, Jennifer Anderson, Etienne Utiger, Gisela Ferreira
    Biologicals 2024 85
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 69 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 69, Issue 1
January/February 2015
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Viral Inactivation: Low pH and Detergent
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Viral Inactivation: Low pH and Detergent
Laura Durno, Omar Tounekti
PDA Journal of Pharmaceutical Science and Technology Jan 2015, 69 (1) 163-172; DOI: 10.5731/pdajpst.2015.01040

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Viral Inactivation: Low pH and Detergent
Laura Durno, Omar Tounekti
PDA Journal of Pharmaceutical Science and Technology Jan 2015, 69 (1) 163-172; DOI: 10.5731/pdajpst.2015.01040
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Introduction
    • Virus Inactivation At Low Ph: Impact of Buffers, Ph Value, Protein Concentration, and Temperature On the Inactivation of Retroviruses (Franz Nothelfer, Hans-Georg Bischof, Helmut Winter, Joey Studts, Boehringer Ingelheim Pharma Gmbh & Co. Kg; Alice Marinaci and Horst Ruppach, Charles River Biopharmaceutical Services)
    • Method of Inactivating Enveloped Viruses Using Eco-friendly, Cost Effective, Zwitterionic Detergents (Lynn Conley, Biogen Idec)
    • Investigation of Alternative and Eco-friendly Detergents for Viral Inactivation (S. Fisher and L. Norling, Genentech)
    • XMuLV Inactivation By Triton X-100: Impact of Process Conditions and Points of Use (Shivanthi Chinniah and Lisa Connell-Crowley, Amgen)
    • Summary
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Using Sensitivity Analysis to Simplify the Virus Safety Factor Calculation in the Manufacture of Biopharmaceuticals
  • The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim
  • Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
  • Google Scholar

More in this TOC Section

Proceedings of the 2013 Viral Clearance Symposium

  • Session 2/3: Integrated Viral Clearance Strategy and Case Studies
  • Viral Clearance of Traditional Unit Operations: Virus-Retentive Filtration
  • 2013 Viral Clearance Symposia - Session 5. Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
Show more Proceedings of the 2013 Viral Clearance Symposium

Conference Proceeding

  • Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2—Virus Barrier Filter and HTST
  • Proceedings of the 2017 Viral Clearance Symposium, Session 3: Resin Lifetime
  • Proceedings of the 2017 Viral Clearance Symposium, Session 1.1: Upstream Mitigation, Part 1—Cell Bank and Bulk Harvest Testing
Show more Conference Proceeding

Similar Articles

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire